Viewing Study NCT05507658


Ignite Creation Date: 2025-12-25 @ 12:19 AM
Ignite Modification Date: 2026-01-02 @ 9:15 AM
Study NCT ID: NCT05507658
Status: COMPLETED
Last Update Posted: 2025-11-28
First Post: 2022-08-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tislelizumab Combined With XELOX as Neoadjuvant Therapy for G/GEJ Adenocarcinoma
Sponsor: Xijing Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module